New Alzheimer Drug Gains Full Approval

被引：0
|
作者：
Aschenbrenner, Diane S. [1 ,2 ]
机构：
[1] Notre Dame Maryland Univ, Baltimore, MD 21210 USA
[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA
来源：
AMERICAN JOURNAL OF NURSING | 2023年 / 123卷 / 10期
关键词：
D O I：
10.1097/01.NAJ.0000979084.89835.67
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Following accelerated approval in January, lecanemab (Leqembi) has now received full approval for the treatment of Alzheimer disease.Lecanemab can cause brain swelling or intracerebral hemorrhage. These changes are usually asymptomatic and not serious. Brain imaging monitoring is required before and during treatment.
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
12345